A Single-Pot Template Reaction Towards a Manganese-Based T₁ Contrast Agent

Area of Science:

• Magnetic Resonance Imaging (MRI)
• Contrast Agents
• Manganese Chemistry

Background:

• Gadolinium-based contrast agents (GdCAs) face limitations due to kinetic lability and complex synthesis.
• Manganese-based contrast agents (MnCAs) offer a potential alternative but require improved properties for clinical use.

Purpose of the Study:

• To develop and characterize a novel manganese-based contrast agent (MnCA) with improved physicochemical properties.
• To evaluate the in vitro and in vivo performance of the new MnCA, MnL^Me.

Main Methods:

• A single-pot template synthesis strategy was employed to create the MnCA, MnL^Me.
• In vitro physicochemical properties, including relaxivity, were measured at various magnetic field strengths.
• In vivo studies assessed renal excretion, blood half-life, and compared performance to a commercial GdCA (Magnevist).

Main Results:

• MnL^Me demonstrated optimized r₁ relaxivities across a range of magnetic field strengths.
• Enhanced binding to bovine serum albumin (BSA) resulted in an increased r₁^b relaxivity.
• In vivo studies confirmed intact renal excretion and a prolonged blood half-life compared to Magnevist.

Conclusions:

• The novel MnCA, MnL^Me, exhibits favorable in vitro and in vivo characteristics.
• Its optimized relaxivity and improved pharmacokinetic profile suggest significant potential as a next-generation MRI contrast agent.